Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Acute Kidney Injury Market?

There has been robust expansion in the acute kidney injury market recently. We expect it to increase from $5.37 billion in 2024 to $5.72 billion in 2025, yielding a compound annual growth rate (CAGR) of 6.6%. The upsurge during the historic period is credited to the escalating prevalence of chronic illnesses, the growth of the elderly population, the rise in hospital-acquired infections, heightened awareness concerning renal health, and advancements in critical care medicine.

Expectations are high for the acute kidney injury market as it’s forecasted for substantial expansion in the next few years. By the year 2029, it will have reached a valuation of $7.33 billion, propelled by a compound annual growth rate (CAGR) of 6.4%. This notable growth during the projected period can be associated with factors such as the increasing occurrence of sepsis, escalating demand for individualized treatment plans, amplified governmental efforts towards healthcare, and the rise in healthcare expenditure in up-and-coming markets. The forecasted period will also see major trends such as the presence of wearable dialysis devices, the use of artificial intelligence for optimizing treatment, the advent of portable renal replacement therapy systems, advancements in continuous renal replacement therapy (CRRT), and the incorporation of remote monitoring and telemedicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Drivers Are Accelerating Expansion Of The Acute Kidney Injury Market?

The escalating rate of diabetes is anticipated to fuel the expansion of the acute kidney injury market. Diabetes constitutes a collective term for metabolic ailments characterized by elevated glucose levels, due to either inadequate insulin production by the body or unresponsiveness of body cells to insulin. Spikes in diabetes rates are attributable to influences like increased rates of obesity, deficient diets, sedentary living habits, aged populations, and improved cognizance and diagnosis. Acute kidney injury ignites metabolic and inflammatory variations which can affect insulin resistance and glucose equilibrium, manifesting a complex network that could affect the advancement and management of diabetes. For example, in March 2024, the Office for Health Improvement & Disparities, a government department in the UK, stated that from March 2022 to March 2023, the portion of people with type 1 diabetes undertaking all eight suggested care processes escalated by 22%, and for type 2 diabetes, it rose by 21%. Meanwhile, the proportion reaching the target HbA1c levels went up to 37.9%, the supreme value ever accounted by the National Diabetes Audit (NDA). Hence, the expanding prevalence of diabetes is bolstering the growth of the acute kidney injury market.

What Are The Key Segment Trends Observed In The Acute Kidney Injury Market?

The acute kidney injurymarket covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury; Post-Renal Kidney Injury; Intrinsic Kidney Injury

2) By Treatment Type: Dialysis; Drug Therapy; Urinary Implants

3) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia; Heart Failure-Related Injury; Sepsis-Induced Injury; Renal Artery Stenosis; Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction; Bladder Outlet Obstruction; Prostate Enlargement (Benign Prostatic Hyperplasia); Kidney Stones; Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN); Acute Interstitial Nephritis (AIN); Glomerulonephritis; Vasculitis; Rhabdomyolysis-Induced Injury

Which Long-Term Trends Will Play A Crucial Role In The Acute Kidney Injury Market?

Leading businesses in the acute kidney injury (AKI) market are concentrating on securing regulatory greenlights to expand their product offerings and provide innovative treatments. These regulatory sanctions are permissions awarded by regulatory authorities like the FDA or EMA, which allow the distribution and selling of a product once it fulfills certain safety, effectiveness, and quality criteria. For example, Mission Therapeutics Ltd., a UK biotechnology firm, was granted FDA approval in December 2023 to commence a Phase II clinical trial for its chief candidate, MTX652, aimed at treating AKI in high-risk heart surgery patients. The drug is engineered to target essential pathways related to kidney damage and repair, with goals to decrease inflammation, prevent further harm to the kidney, and encourage recovery. A notable aspect of this trial is its emphasis on utilizing new therapeutic mechanisms to address the root molecular reasons behind AKI, possibly providing more successful treatment alternatives than current interventions. The Phase II trial will assess MTX652’s safety, effectiveness, and pharmacokinetics, delivering crucial information that could propel wider clinical usage and potential regulatory approval.

Who Are The Major Stakeholders Operating In The Acute Kidney Injury Market?

Major companies operating in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

What Regional Factors Are Accelerating Growth In The Acute Kidney Injury Market?

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Browse Through More Reports Similar to the Global Acute Kidney Injury Market 2025, By The Business Research Company

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Artificial Kidney Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model